Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Posted on by The Scientist

Mr. Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Associate Professor |  Hebei University | China

Dr. Zhang Guowei is an active researcher whose work advances the understanding of psychological health, behavioral patterns, and population-level mental well-being, particularly among young adults in contemporary social environments. His academic influence is demonstrated through 347 citations, 20 publications, and an h-index of 10, reflecting a growing global presence and measurable scholarly impact. His research portfolio integrates empirical analysis, psychometric assessment, and digital-behavior analytics to examine how social, environmental, and technological factors shape mental health outcomes. Dr. Zhang’s contributions include impactful studies on anxiety, depression, insomnia, and PTSD among university students, offering timely insights into evolving psychosocial challenges in the post-pandemic era. His work on time-based online survey patterns and their relationship with offline psychological symptoms provides a novel methodological approach, highlighting his ability to connect digital behavioral traces with real-world psychological states. Through these interdisciplinary inquiries, he addresses urgent public-health concerns and informs evidence-based interventions. With a collaborative network spanning over 70 co-authors, Dr. Zhang actively participates in multi-institutional and cross-regional research efforts. This broad collaborative engagement enhances the robustness of his findings and contributes to the global dialogue on mental health resilience, student well-being, and psychosocial risk assessment. His publications in reputable international journals underscore his commitment to research transparency, open access, and data-driven decision-making. Dr. Zhang’s ongoing work strengthens the academic and societal understanding of mental-health dynamics in rapidly changing environments, emphasizing early detection, preventive strategies, and policy relevance. His scholarly trajectory continues to advance applied psychological research, contributing meaningful evidence to public health systems, educational institutions, and community well-being initiatives worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Xiong, J.-M., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining.

  2. Fu, Z.-T., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). The mechanism of TCM prevention and treatment of heavy COVID-19 based on data mining and network pharmacology.

  3. Zhang, L.-H., Zhang, W.-Y., Xiong, J.-M., … Zhang, G.-W. (2022). Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

  4. Cui, Q., Ma, Y., Yu, H., … Zhang, G.-W. (2021). Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.

  5. Zhang, L., Zhang, W., Xiong, J., … Zhang, G.-W. (2020). Mechanisms of Compound Kushen Injection for treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Prof in General Practice | University of Tasmania | Australia

Professor Jan Radford is a distinguished academic in general practice and medical education, currently based at the Tasmanian School of Medicine, University of Tasmania. With over three decades of professional and academic experience, she has contributed extensively to curriculum design, health professional education, and research capacity building within primary care. She has authored 59 peer-reviewed publications, which have collectively received over 535 citations, reflecting her sustained influence in the field. Professor Radford’s scholarly and leadership contributions span undergraduate, postgraduate, and vocational levels of medical education. As a long-serving faculty member, she has played a pivotal role in shaping the University of Tasmania’s medical curriculum, particularly through initiatives such as the development of innovative rural and aged care placements. Her leadership as Director of the Launceston Clinical School (2022–2024) further strengthened community-based clinical education and interprofessional collaboration across Tasmania. Nationally, she has held major roles in the Royal Australian College of General Practitioners (RACGP), notably serving as Censor-in-Chief, where she oversaw educational quality assurance, specialty recognition, and the advancement of Indigenous health education. Her work in developing the GP MAGIC framework and establishing Tasmania’s practice-based research network has fostered practitioner-led inquiry and evidence-informed primary care. A 2017 Churchill Fellow, Professor Radford investigated the use of routinely collected general practice electronic health data to enhance patient outcomes. This aligns with her ongoing research focus on integrating e-health data, clinical audit, and educational innovation to improve general practice systems and learning environments. Through her extensive collaborations and commitment to translating research into practice, Professor Radford continues to influence healthcare education and delivery in Australia and beyond, contributing meaningfully to the advancement of community-oriented, data-informed primary care.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Radford, J., et al. (2021). Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung and Circulation, 30(3), 324–349. https://doi.org/10.1016/j.hlc.2020.10.013 — 108 citations

  2. Fan, S., Radford, J., & Fabian, D. (2016). A mixed-method research to investigate the adoption of mobile devices and Web 2.0 technologies among medical students and educators. BMC Medical Informatics and Decision Making, 16(1), 43. https://doi.org/10.1186/s12911-016-0282-4 — 52 citations

  3. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., Salahudeen, M. S., et al. (2022). Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: A population-based cohort study. Journal of the American Heart Association, 11(7), e023098. https://doi.org/10.1161/JAHA.121.023098 — 46 citations

  4. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Radford, J., et al. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. https://doi.org/10.1186/s12882-020-01849-7 — 37 citations

  5. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., & Curtain, C. (2021). Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Frontiers in Pharmacology, 12, 586370. https://doi.org/10.3389/fphar.2021.586370 — 36 citations